{"entity":{"type":"insider","cik":"0001789032","url":"/insider/0001789032","json_url":"/insider/0001789032.json","name":"Korbel Gregory Alan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2019-10-07","last":"2021-12-03","span_basis":"filed_date"},"name_variants":[{"name":"Korbel Gregory Alan","source":"filing","n_filings":5,"first_seen":"2019-10-07","last_seen":"2021-12-03"}],"transactions":[{"id":4211715,"accession":"0001104659-21-146396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-146396","line_url":"/filing/0001104659-21-146396#line-2","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789032","owner_name":"Korbel Gregory Alan","owner_display_name":"Korbel Gregory Alan","owner_url":"/insider/0001789032","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":108900.0,"total_display":"108,900.00","total_whole":"108,900","shares_owned_after":17167.0,"shares_owned_after_display":"17,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":4987956,"accession":"0001104659-21-133785","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-133785","line_url":"/filing/0001104659-21-133785#line-2","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789032","owner_name":"Korbel Gregory Alan","owner_display_name":"Korbel Gregory Alan","owner_url":"/insider/0001789032","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":137500.0,"total_display":"137,500.00","total_whole":"137,500","shares_owned_after":17167.0,"shares_owned_after_display":"17,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4673716,"accession":"0001104659-21-123185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-123185","line_url":"/filing/0001104659-21-123185#line-2","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789032","owner_name":"Korbel Gregory Alan","owner_display_name":"Korbel Gregory Alan","owner_url":"/insider/0001789032","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":134475.0,"total_display":"134,475.00","total_whole":"134,475","shares_owned_after":17167.0,"shares_owned_after_display":"17,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":5441119,"accession":"0001104659-21-118363","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-118363","line_url":"/filing/0001104659-21-118363","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789032","owner_name":"Korbel Gregory Alan","owner_display_name":"Korbel Gregory Alan","owner_url":"/insider/0001789032","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32960.0,"shares_display":"32,960","price_per_share":4.971656553398058,"price_display":"4.97","price_state":"stated","total_value":163865.8,"total_display":"163,865.80","total_whole":"163,866","shares_owned_after":17167.0,"shares_owned_after_display":"17,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider","n_lines":2},{"id":8482331,"accession":"0001140361-19-018077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-19-018077","line_url":"/filing/0001140361-19-018077#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789032","owner_name":"Korbel Gregory Alan","owner_display_name":"Korbel Gregory Alan","owner_url":"/insider/0001789032","role":"Officer (VP of Business Dev't)","role_mark":"O","role_mark_label":"Officer (VP of Business Dev't)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Business Dev't","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":7500.0,"total_display":"7,500.00","total_whole":"7,500","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-07","filed_date":"2019-10-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Officer (SVP, Chief Business Officer)","n_filings":5,"first_seen":"2019-10-07","last_seen":"2021-12-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789032","retrieved_at":"2026-08-26T22:53:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}